Organ-Specific Comorbidities Are Associated With Distinct Complications After Liver Transplantation for Biliary

Sarah A Taylor1, Veena Venkat, Ronen Arnon

  • 1Department of Pediatrics Ann and Robert H. Lurie Children's Hospital of Chicago Chicago IL Department of Pediatrics University of Pittsburgh Medical Center Pittsburgh PA Department of Pediatrics Mount Sinai School of Medicine New York NY Department of Pediatrics Levine Children's Hospital at Atrium Health Charlotte NC Department of Pediatrics and Surgery University of California San Francisco San Francisco CA The Emmes Company LLC Rockville MD Department of Pediatrics Children's Mercy Hospital Kansas City MO.

Insights

Patients with biliary atresia (BA) and comorbidities face higher transplant risks, including graft loss and infection. However, comorbidities did not significantly increase patient death rates post-transplant.

Area of Science:

  • Hepatology
  • Pediatric Gastroenterology
  • Transplantation Immunology

Background:

  • Biliary atresia (BA) liver transplant outcomes have improved.
  • Predicting post-transplant complications in BA patients with comorbidities remains challenging.

Purpose of the Study:

  • To define the impact of comorbidities on post-transplant outcomes in biliary atresia (BA) patients.
  • To identify risk factors for graft and patient loss in BA patients with comorbidities.

Main Methods:

  • Analysis of 1034 BA patients from the Society of Pediatric Liver Transplantation registry (2011-2019).
  • Patients grouped by comorbidities (>1.0% incidence): supplemental feeding, dialysis, other abdominal surgery, hepatopulmonary syndrome, cardiac disease.
  • Statistical analysis included Kruskal-Wallis, chi-square, log-rank tests, Cox proportional hazards models, and logistic regression.

Main Results:

  • 77% of BA patients had comorbidities, showing greater medical acuity (higher PELD scores, ICU admissions).
  • Comorbid BA patients experienced more graft loss, longer hospitalizations, intubation, reoperations, and infections within 30 days post-transplant.
  • Lower z-weight and higher creatinine were risk factors for graft/patient loss; prior Kasai portoenterostomy (KPE) was protective against infection and vascular complications.

Conclusions:

  • BA patients with comorbidities have higher medical acuity and reduced graft survival but not significantly increased patient death.
  • Findings aid in risk-stratifying BA patients for post-transplant outcomes.
  • Organ-system-specific data can refine prognostic assessments for BA liver transplantation.

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
565
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.4K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
410
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
575
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
77
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
91